Cerus Current Ratio 2006-2019 | CERS

Cerus current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Cerus Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.14B $0.05B 2.84
2018-12-31 $0.15B $0.05B 2.79
2018-09-30 $0.15B $0.04B 3.48
2018-06-30 $0.14B $0.03B 5.03
2018-03-31 $0.13B $0.02B 5.66
2017-12-31 $0.09B $0.02B 3.89
2017-09-30 $0.09B $0.02B 3.71
2017-06-30 $0.07B $0.03B 2.94
2017-03-31 $0.08B $0.03B 2.86
2016-12-31 $0.09B $0.03B 3.50
2016-09-30 $0.11B $0.02B 4.72
2016-06-30 $0.11B $0.03B 4.36
2016-03-31 $0.12B $0.02B 5.23
2015-12-31 $0.13B $0.02B 5.97
2015-09-30 $0.13B $0.02B 6.45
2015-06-30 $0.14B $0.02B 6.50
2015-03-31 $0.14B $0.02B 5.99
2014-12-31 $0.08B $0.03B 2.57
2014-09-30 $0.07B $0.02B 3.44
2014-06-30 $0.07B $0.02B 3.24
2014-03-31 $0.07B $0.03B 2.46
2013-12-31 $0.08B $0.04B 1.98
2013-09-30 $0.08B $0.04B 1.75
2013-06-30 $0.08B $0.03B 2.95
2013-03-31 $0.09B $0.03B 3.16
2012-12-31 $0.04B $0.03B 1.72
2012-09-30 $0.04B $0.03B 1.60
2012-06-30 $0.04B $0.02B 1.80
2012-03-31 $0.05B $0.03B 1.70
2011-12-31 $0.04B $0.02B 1.88
2011-09-30 $0.03B $0.01B 2.16
2011-06-30 $0.03B $0.02B 1.49
2011-03-31 $0.04B $0.02B 1.77
2010-12-31 $0.04B $0.02B 2.12
2010-09-30 $0.03B $0.02B 1.72
2010-06-30 $0.03B $0.01B 2.07
2010-03-31 $0.03B $0.01B 2.79
2009-12-31 $0.03B $0.01B 2.51
2009-09-30 $0.04B $0.02B 2.25
2009-06-30 $0.03B $0.01B 2.33
2009-03-31 $0.03B $0.01B 2.94
2008-12-31 $0.04B $0.01B 3.26
2008-09-30 $0.05B $0.01B 3.82
2008-06-30 $0.06B $0.02B 3.69
2008-03-31 $0.07B $0.01B 4.74
2007-12-31 $0.07B $0.02B 4.03
2007-09-30 $0.08B $0.02B 5.13
2007-06-30 $0.09B $0.01B 6.22
2007-03-31 $0.09B $0.01B 8.36
2006-12-31 $0.10B $0.02B 6.94
2006-09-30 $0.08B $0.02B 5.13
2006-06-30 $0.08B $0.02B 4.85
2006-03-31 $0.09B $0.02B 4.26
2005-12-31 $0.05B $0.02B 2.19
2005-09-30 $0.05B $0.01B 4.10
2005-06-30 $0.06B $0.01B 4.10
2005-03-31 $0.06B $0.02B 3.98
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.704B $0.061B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.425B 25.90
Medtronic (MDT) Ireland $122.903B 17.56
Stryker (SYK) United States $68.838B 24.57
Boston Scientific (BSX) United States $52.553B 25.19
Baxter (BAX) United States $38.278B 24.13
Zimmer Biomet Holdings (ZBH) United States $23.339B 14.99
Smith & Nephew SNATS (SNN) United Kingdom $18.382B 0.00
ResMed (RMD) United States $16.166B 30.89
Canopy Growth (CGC) Canada $15.335B 0.00
Bio-Rad Laboratories (BIO) United States $8.760B 46.44
Aurora Cannabis (ACB) Canada $8.366B 82.50
Perrigo (PRGO) Ireland $6.496B 10.98
Hill-Rom Holdings (HRC) United States $6.448B 19.55
Insulet (PODD) United States $6.300B 459.00
GW Pharmaceuticals (GWPH) United Kingdom $5.571B 0.00
Haemonetics (HAE) United States $5.072B 41.44
ICU Medical (ICUI) United States $4.628B 27.61
Hutchison China MediTech (HCM) China $3.586B 0.00
NuVasive (NUVA) United States $3.167B 25.86
Neogen (NEOG) United States $2.950B 47.97
Agios Pharmaceuticals (AGIO) United States $2.882B 0.00
National Vision Holdings (EYE) United States $2.217B 47.23
Quidel (QDEL) United States $2.167B 22.49
Aphria (APHA) $1.607B 0.00
HEXO (HEXO) $1.406B 0.00
Cardiovascular Systems (CSII) United States $1.356B 778.60
Phibro Animal Health (PAHC) United States $1.204B 18.04
AtriCure (ATRC) United States $1.132B 0.00
VAREX IMAGING (VREX) United States $1.038B 22.04
Lantheus Holdings (LNTH) United States $0.944B 25.07
NanoString Technologies (NSTG) United States $0.941B 0.00
Omeros (OMER) United States $0.931B 0.00
MacroGenics (MGNX) United States $0.909B 0.00
PetIQ (PETQ) United States $0.774B 18.80
Eagle Pharmaceuticals (EGRX) United States $0.746B 20.91
TG Therapeutics (TGTX) United States $0.626B 0.00
Surmodics (SRDX) United States $0.533B 77.49
LeMaitre Vascular (LMAT) United States $0.516B 24.99
OraSure Technologies (OSUR) United States $0.507B 23.34
Quanterix (QTRX) United States $0.502B 0.00
Meridian Bioscience (VIVO) United States $0.484B 14.81
Evolus (EOLS) United States $0.463B 0.00
BioLife Solutions (BLFS) United States $0.331B 103.71
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.327B 0.00
Utah Medical Products (UTMD) United States $0.289B 20.04
Vapotherm (VAPO) United States $0.278B 0.00
Rockwell Medical (RMTI) United States $0.275B 0.00
Zynex (ZYXI) United States $0.231B 23.83
Owens & Minor (OMI) United States $0.217B 4.60
Cytosorbents (CTSO) United States $0.212B 0.00
Bovie Medical (APYX) United States $0.190B 0.00
Chimerix (CMRX) United States $0.179B 0.00
Fonar (FONR) United States $0.129B 6.77
Chembio Diagnostics (CEMI) United States $0.122B 0.00
BRAINSWAY LTD (BWAY) Israel $0.116B 0.00
Surface Oncology (SURF) United States $0.110B 0.00
Female Health (VERU) United States $0.108B 0.00
InfuSystems Holdings (INFU) United States $0.100B 0.00
United-Guardian (UG) United States $0.094B 20.59
Neurotrope (NTRP) United States $0.092B 0.00
Insys Therapeutics (INSY) United States $0.061B 0.00
Trinity Biotech (TRIB) Ireland $0.057B 19.65
Oramed Pharmaceuticals (ORMP) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
GUARDION HEALTH (GHSI) United States $0.042B 0.00
Senestech (SNES) United States $0.039B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.027B 0.00
Myomo (MYO) United States $0.016B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.006B 4.56